Brian Badgwell, MD, MS
BOSTON—A place for preoperative chemoradiation in addition to chemotherapy as a neoadjuvant treatment strategy for resectable gastric adenocarcinoma was debated at the Society of Surgical Oncology’s 2023 International Conference on Surgical Cancer Care, where Brian Badgwell, MD, MS, and Vivian E. Strong, MD, discussed the relative merits of each strategy. While there still seems to be no clear-cut answer to the question, the presenters